Comments
Loading...
Agios Pharmaceuticals Insider Trading Activity | NASDAQ:AGIO | Benzinga
Track the latest Agios Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Agios Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Agios Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Agios Pharmaceuticals Inc
Shares Outstanding
57.915M
Insider Shares Owned
1.340M
Insider Percentage Owned
2.31%
Institutional Shares Held
32.191M
Institutional Percentage Held
55.6%
| Apr 10, 2025 | Jacqualyn Fouse | DIRECTOR | 8.44K | $25.90 | -$194.17K | SELL-OPTIONS | 5.99% | 149.22K | Apr 08 - Apr 10 | View |
| Mar 04, 2025 | James Burns | CHIEF LEGAL OFFICER | 9.49K | $35.54 | -$142.34K | SELL-OPTIONS | 59.51% | 25.45K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 5.39K | $35.54 | -$80.85K | SELL-OPTIONS | 26.38% | 25.83K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 3.99K | $35.54 | -$59.74K | SELL-OPTIONS | 21.08% | 22.89K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Brian Goff | CHIEF EXECUTIVE OFFICER | 13.55K | $35.54 | -$460.14K | SELL-OPTIONS | 17.20% | 92.34K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 9.49K | $35.54 | -$142.34K | SELL-OPTIONS | 21.38% | 53.90K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 3.92K | $35.54 | -$58.82K | SELL-OPTIONS | 71.41% | 9.41K | Mar 01 - Mar 03 | View |
| Feb 05, 2025 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 4.62K | $34.39 | -$78.13K | SELL-OPTIONS | 568.76% | 5.44K | Feb 01 - Feb 05 | View |
| Jan 07, 2025 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 5.67K | $32.18 | -$90.23K | SELL-OPTIONS | 42.86% | 18.91K | Jan 03 - Jan 06 | View |
| Dec 13, 2024 | David Scadden | DIRECTOR | 0.00 | $32.19 | -$5.64K | SELL-OPTIONS | 0.00% | 15.48K | Dec 11 | View |
| Nov 13, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -772.00 | $56.09 | -$43.30K | SELL | -48.71% | 813.00 | Nov 08 | View |
| Nov 12, 2024 | Rahul Ballal | DIRECTOR | 0.00 | $40.92 | -$597.35K | SELL-OPTIONS | 0.00% | 7.99K | Nov 07 - Nov 08 | View |
| Nov 12, 2024 | James Burns | CHIEF LEGAL OFFICER | -21.75K | $52.21 | -$1.14M | SELL | -58.08% | 15.70K | Nov 07 | View |
| Sep 30, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 4.93K | $49.03 | -$124.63K | SELL-OPTIONS | 32.38% | 20.16K | Sep 26 | View |
| Aug 12, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 11.60K | $42.75 | -$474.14K | SELL-OPTIONS | 17.26% | 78.79K | Aug 08 | View |
| Jul 03, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.67K | $43.85 | -$162.46K | SELL-OPTIONS | 11.95% | 43.74K | Jul 01 | View |
| Jun 07, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 13.41K | $48.84 | -$591.70K | SELL-OPTIONS | 24.94% | 67.19K | Jun 05 | View |
| Jun 05, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -1.36K | $44.39 | -$60.46K | SELL | -47.19% | 1.52K | Jun 03 | View |
| Apr 10, 2024 | Jacqualyn Fouse | DIRECTOR | 8.14K | $27.55 | -$214.64K | SELL-OPTIONS | 6.30% | 137.40K | Apr 08 - Apr 10 | View |
| Mar 11, 2024 | Kaye FosterCheek | DIRECTOR | -1.28K | $31.62 | -$40.63K | SELL | -14.26% | 7.72K | Mar 07 | View |
| Mar 07, 2024 | Kaye FosterCheek | DIRECTOR | -4.71K | $32.00 | -$150.90K | SELL | -34.36% | 9.01K | Mar 05 - Mar 06 | View |
| Mar 07, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -1.91K | $31.75 | -$60.74K | SELL | -39.86% | 2.89K | Mar 05 | View |
| Mar 05, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 5.19K | $32.57 | -$86.05K | SELL-OPTIONS | 15.33% | 39.07K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 1.33K | $32.57 | -$21.89K | SELL-OPTIONS | 9.83% | 14.84K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 1.91K | $32.57 | -$39.54K | SELL-OPTIONS | 66.29% | 4.80K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 4.34K | $32.57 | -$135.36K | SELL-OPTIONS | 8.79% | 53.78K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | James Burns | CHIEF LEGAL OFFICER | 5.19K | $32.57 | -$86.05K | SELL-OPTIONS | 16.24% | 37.17K | Mar 01 - Mar 05 | View |
| Feb 29, 2024 | David Schenkein | DIRECTOR | 0.00 | $33.15 | -$210.02K | SELL-OPTIONS | 0.00% | 201.94K | Feb 27 | View |
| Feb 27, 2024 | David Schenkein | DIRECTOR | 0.00 | $32.37 | -$98.94K | SELL-OPTIONS | 0.00% | 201.94K | Feb 23 - Feb 26 | View |
| Feb 22, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -504.00 | $26.63 | -$13.42K | SELL | -15.53% | 2.74K | Feb 20 | View |
| Feb 14, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 1.52K | $25.14 | -$16.14K | SELL-OPTIONS | 4.76% | 33.43K | Feb 12 - Feb 14 | View |
| Feb 14, 2024 | James Burns | CHIEF LEGAL OFFICER | 1.29K | $25.14 | -$13.70K | SELL-OPTIONS | 4.24% | 31.67K | Feb 12 - Feb 14 | View |
| Feb 14, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 504.00 | $25.14 | -$6.86K | SELL-OPTIONS | 18.39% | 3.25K | Feb 12 - Feb 14 | View |
| Jan 24, 2024 | James Burns | CHIEF LEGAL OFFICER | 4.04K | $21.64 | -$36.96K | SELL-OPTIONS | 15.35% | 30.38K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.04K | $21.64 | -$36.96K | SELL-OPTIONS | 14.50% | 31.91K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 3.49K | $21.64 | -$40.81K | SELL-OPTIONS | 36.49% | 13.07K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Jacqualyn Fouse | DIRECTOR | 13.18K | $21.64 | -$232.02K | SELL-OPTIONS | 11.35% | 129.25K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 9.38K | $21.64 | -$165.22K | SELL-OPTIONS | 23.43% | 49.44K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 3.83K | $21.64 | -$35.01K | SELL-OPTIONS | 40.73% | 13.23K | Jan 20 - Jan 24 | View |
| Jan 09, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 13.46K | $22.99 | -$277.40K | SELL-OPTIONS | 50.62% | 40.05K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | Jacqualyn Fouse | DIRECTOR | 9.11K | $22.99 | -$192.91K | SELL-OPTIONS | 8.52% | 116.08K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | James Burns | CHIEF LEGAL OFFICER | 2.09K | $22.99 | -$26.74K | SELL-OPTIONS | 8.61% | 26.34K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 3.21K | $22.99 | -$41.13K | SELL-OPTIONS | 13.02% | 27.87K | Jan 05 - Jan 09 | View |
| Jan 05, 2024 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 5.57K | $22.32 | -$64.77K | SELL-OPTIONS | 145.47% | 9.40K | Jan 03 - Jan 05 | View |
| Sep 28, 2023 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 5.29K | $24.79 | -$54.02K | SELL-OPTIONS | 123.61% | 9.57K | Sep 26 - Sep 28 | View |
| Aug 21, 2023 | James Burns | CHIEF LEGAL OFFICER | -6.39K | $26.28 | -$168.06K | SELL | -21.12% | 23.89K | Aug 17 | View |
| Aug 11, 2023 | Kaye FosterCheek | DIRECTOR | 0.00 | $22.02 | -$196.64K | SELL-OPTIONS | 0.00% | 13.72K | Aug 09 | View |
| Aug 10, 2023 | Brian Goff | CHIEF EXECUTIVE OFFICER | 12.51K | $25.48 | -$259.34K | SELL-OPTIONS | 88.88% | 26.59K | Aug 08 | View |
| Aug 09, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -2.92K | $25.39 | -$74.10K | SELL | -51.56% | 2.74K | Aug 07 | View |
| Aug 02, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 2.92K | $26.26 | -$32.35K | SELL-OPTIONS | 106.46% | 5.66K | Aug 01 | View |
| Jun 30, 2023 | James Burns | CHIEF LEGAL OFFICER | 4.04K | $28.36 | -$48.41K | SELL-OPTIONS | 15.41% | 30.29K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Jacqualyn Fouse | DIRECTOR | 13.18K | $28.36 | -$303.96K | SELL-OPTIONS | 14.06% | 106.97K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.04K | $28.36 | -$48.41K | SELL-OPTIONS | 20.10% | 24.16K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Brian Goff | CHIEF EXECUTIVE OFFICER | 14.08K | $28.36 | -$324.69K | SELL-OPTIONS | ∞ | 14.08K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 3.78K | $28.36 | -$45.29K | SELL-OPTIONS | ∞ | 3.78K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 3.83K | $28.36 | -$45.89K | SELL-OPTIONS | ∞ | 3.83K | Jun 28 - Jun 30 | View |
| Apr 05, 2023 | David Schenkein | DIRECTOR | 0.00 | $15.95 | -$225.81K | SELL-OPTIONS | 0.00% | 196.96K | Apr 03 | View |
| Mar 29, 2023 | David Schenkein | DIRECTOR | 0.00 | $15.60 | -$262.00K | SELL-OPTIONS | 0.00% | 196.96K | Mar 27 | View |
| Mar 15, 2023 | David Schenkein | DIRECTOR | 0.00 | $15.77 | -$268.82K | SELL-OPTIONS | 0.00% | 196.96K | Mar 13 | View |
| Mar 07, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -504.00 | $24.29 | -$12.24K | SELL | -15.53% | 2.74K | Mar 03 | View |
| Mar 01, 2023 | David Schenkein | DIRECTOR | 0.00 | $17.21 | -$326.40K | SELL-OPTIONS | 0.00% | 196.96K | Feb 27 | View |
| Feb 21, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -233.00 | $27.21 | -$6.34K | SELL | -8.03% | 2.67K | Feb 16 | View |
| Feb 16, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -271.00 | $28.65 | -$18.08K | SELL | -8.54% | 2.90K | Feb 14 | View |
| Feb 15, 2023 | David Schenkein | DIRECTOR | 0.00 | $18.84 | -$391.40K | SELL-OPTIONS | 0.00% | 196.96K | Feb 13 | View |
| Feb 01, 2023 | David Schenkein | DIRECTOR | 0.00 | $19.19 | -$405.58K | SELL-OPTIONS | 0.00% | 196.96K | Jan 30 | View |
| Jan 19, 2023 | David Schenkein | DIRECTOR | 0.00 | $18.95 | -$396.09K | SELL-OPTIONS | 0.00% | 196.96K | Jan 17 | View |
| Mar 01, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -108.00 | $30.00 | -$3.24K | SELL | -4.06% | 2.55K | Feb 25 | View |
| Feb 18, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -233.00 | $30.81 | -$7.18K | SELL | -8.38% | 2.55K | Feb 16 | View |
| Feb 16, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -271.00 | $31.10 | -$19.62K | SELL | -8.88% | 2.78K | Feb 14 | View |
| Jun 23, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $56.56 | -$17.95K | SELL-OPTIONS | 0.00% | 0.00 | Jun 21 | View |
| Jun 22, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0.00 | $55.05 | -$490.86K | SELL-OPTIONS | 0.00% | 15.49K | Jun 18 | View |
| Jun 21, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0.00 | $49.89 | -$50.69K | SELL-OPTIONS | 0.00% | 15.49K | Jun 17 | View |
| Jun 11, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0.00 | $49.92 | -$569.19K | SELL-OPTIONS | 0.00% | 15.49K | Jun 09 - Jun 10 | View |
| Jun 09, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0.00 | $49.91 | -$222.08K | SELL-OPTIONS | 0.00% | 15.49K | Jun 07 - Jun 08 | View |
| May 18, 2021 | Darrin Miles | CHIEF COMMERCIAL OFFICER | -3.46K | $55.41 | -$191.83K | SELL | -32.44% | 7.21K | May 14 | View |
| Apr 21, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0.00 | $45.38 | -$342.75K | SELL-OPTIONS | 0.00% | 15.49K | Apr 19 - Apr 20 | View |
| Apr 20, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | -1.12K | $55.89 | -$62.49K | SELL | -100.00% | 0.00 | Apr 16 | View |
| Apr 16, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | -991.00 | $54.00 | -$53.51K | SELL | -46.99% | 1.12K | Apr 15 | View |
| Mar 16, 2021 | Darrin Miles | CHIEF COMMERCIAL OFFICER | -2.70K | $48.10 | -$129.87K | SELL | -20.19% | 10.67K | Mar 01 - Mar 05 | View |
| Sep 04, 2020 | Carman Alenson | — | -250.00 | $39.93 | -$9.98K | SELL | -57.60% | 184.00 | Sep 02 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
